Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Int J Pediatr Endocrinol ; 2020: 11, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32536946

RESUMO

BACKGROUND: Youth onset type 1 diabetes (T1D) and type 2 diabetes (T2D) is increasing and associated with earlier vascular complications and mortality. Dyslipidemia is an important modifiable cardiovascular (CVD) risk factor that is under-recognized and undertreated in youth with T1D and T2D. Given this, we evaluated the prevalence and associations between lipid concentrations and clinical CVD risk factors in youth with T1D compared to T2D at our large ethnically diverse diabetes center. METHODS: A retrospective chart review was performed, evaluating patients with T1D or T2D seen at least once in clinic from 2015 to 2017, age 10-22 years of age, duration of diabetes at least 6 months on the date of most recent LDL-cholesterol (LDL-C) concentration, and not on statin therapy. We performed independent and multivariable linear regressions of LDL-C and HDL-cholesterol (HDL-C) concentrations. RESULTS: There were 32.7% with T1D (n = 1701) and 47.7% with T2D (n = 298) with LDL-C above recommend goal (> 100 mg/dL/2.6 mmol/L). Furthermore, there were 9% with T1D and 16.4% with T2D with LDL > 130 mg/dL (> 3.4 mmol/L), who likely met criteria for starting statin therapy. Higher LDL-C and/or lower HDL-C were associated with increased age, diabetes duration, higher HbA1C, female sex, Hispanic ethnicity, obesity, and T2D. After adjusting for these risk factors in a multivariable linear regression model, the association of higher LDL-C and lower HDL-C was higher with T2D than T1D. CONCLUSIONS: This highlights the need for more aggressive dyslipidemia screening and treatment in youth with diabetes, especially T2D. At our institution we have created and instituted quality improvement algorithms to try to address this need.

2.
J Clin Lipidol ; 13(6): 880-886, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31704104

RESUMO

Children with homozygous familial hypercholesterolemia are at risk for early cardiovascular events secondary to coronary artery disease. Current medical therapy does not ameliorate this risk. Liver transplantation offers the most effective option to reduce circulating levels of low-density lipoprotein cholesterol and thereby reduce risk of cardiovascular events. Angiographic evidence of regression of coronary artery disease is presented.


Assuntos
Doença da Artéria Coronariana/diagnóstico , Doença da Artéria Coronariana/metabolismo , Hiperlipoproteinemia Tipo II/metabolismo , Hiperlipoproteinemia Tipo II/patologia , Transplante de Fígado , Adulto , Cateterismo Cardíaco , Pré-Escolar , Feminino , Humanos , Hiperlipoproteinemia Tipo II/etiologia , Masculino , Linhagem , Receptores de LDL/genética , Receptores de LDL/metabolismo , Adulto Jovem
3.
Congenit Heart Dis ; 13(2): 327-333, 2018 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-29345123

RESUMO

OBJECTIVE: Studies have shown improvement in lipid levels after institution of lifestyle changes in children enrolled in closely monitored programs. There programs are difficult to mimic in real world clinics. We aim to determine if diet and exercise result in improvement in lipid levels in patients seen in a designated lipid clinic in a real life setting. DESIGN: Retrospective review of patients followed for dyslipidemia at the Texas Children's Hospital Lipid Clinic from May 1, 2012 to May 1, 2015. Patients included were seen more than once, had repeat lipid testing, and abnormal baseline lipid levels. Multivariate analysis using mixed models were performed to compare outcomes in patients who did and did not participate in lifestyle change. RESULTS: Of the 268 patients seen within the study period, 174 (56% male, 44% female) met inclusion criteria. Median age was 11 years. Compared to patients who did not make lifestyle changes: patients who made only diet changes demonstrated significant improvement in weight only (slope = -1.55, P-value = .014), and those who made only exercise changes demonstrated significant improvements in serum cholesterol (slope = -22.8, P-value = .017) and non-HDL cholesterol (slope = -28.7, P-value = < .01) levels. Patients who participated in both diet and exercise demonstrated significant improvement in weight (slope = -1.13, P-value = .011), diastolic blood pressure (slope = -1.82, P-value = < .01), and serum lipid levels: LDL (slope = -10.8, P-value = 0.017), HDL (slope = 1.52, P-value = .24), Triglycerides (slope = -0.11, P-value = .033) compared to those who did not make lifestyle changes. CONCLUSIONS: Outpatient management of dyslipidemia is difficult. Only patients who participated in both diet and exercise showed significant improvement in outcomes when compared to those who did not make lifestyle changes.


Assuntos
Dislipidemias/sangue , Terapia por Exercício/métodos , Acontecimentos que Mudam a Vida , Estilo de Vida , Lipídeos/sangue , Adolescente , Criança , Estudos Transversais , Dislipidemias/psicologia , Dislipidemias/reabilitação , Feminino , Seguimentos , Humanos , Masculino , Prognóstico , Estudos Retrospectivos
4.
Cardiol Young ; 26(5): 885-93, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26277874

RESUMO

Advancements in paediatric heart failure management have resulted in improved survival and a focus on long-term outcomes including health-related quality of life. We compared health-related quality of life in children with heart failure with healthy patients, children with chronic conditions, and children with cardiovascular disease. Families (n=63) and children (n=73) aged 2-20 years with heart failure were enrolled and compared with data previously published for healthy patients (n=5480), those with chronic conditions (n=247), and those with cardiovascular disease (n=347). Patients and parents completed the PedsQL 4.0 and the Cardiac 3.0 Module health-related quality-of-life questionnaires. PedsQL scores including Total, Psychosocial Health Summary, and Physical were compared between groups. In general, patients with heart failure had lower scores than the healthy population (p=0.001), and comparable scores with those with chronic conditions. Parents perceived no difference in physical scores for children with heart failure when compared with healthy children, and perceived higher scores for children with heart failure when compared with those with chronic conditions (p⩽0.003). Furthermore, children with heart failure had decremental health-related quality-of-life scores as the American Heart Association stage of heart failure increased, such that patients with stage C heart failure had scores similar to children with severe cardiovascular disease. Children with heart failure reported significantly impaired health-related quality of life compared with healthy children and similar scores compared with children with chronic conditions. Parental perceptions appear to underestimate these impairments. Children with heart failure appear to have progressive impairment of health-related quality of life with advancing stage of heart failure.


Assuntos
Cardiomiopatias/psicologia , Insuficiência Cardíaca/psicologia , Pais/psicologia , Qualidade de Vida , Adolescente , Estudos de Casos e Controles , Criança , Pré-Escolar , Doença Crônica , Estudos Transversais , Feminino , Humanos , Masculino , Pediatria , Percepção , Estudos Prospectivos , Autorrelato , Índice de Gravidade de Doença , Estados Unidos , Adulto Jovem
6.
J Pediatr Nurs ; 30(3): 508-15, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25481862

RESUMO

PURPOSE: The purpose of this study was to engage staff nurses in research in an informative and fun way by determining nurses' preference for sugar-free chocolate chip cookies versus regular chocolate chip cookies. DESIGN AND METHODS: A descriptive, crossover, double-blinded study was performed using a convenience sample of 300 staff nurses. RESULTS: Nurses preferred the texture, flavor, and overall preference of the regular chocolate chip cookie as compared with the sugar-free chocolate chip cookie (p<0.001). IMPLICATIONS: The Great American Cookie Experiment remains a creative teaching strategy to enhance knowledge and engage nurses in the research process.


Assuntos
Materiais de Ensino , Adulto , Atitude do Pessoal de Saúde , Estudos Cross-Over , Método Duplo-Cego , Educação Continuada em Enfermagem , Feminino , Humanos , Masculino , Pesquisa em Enfermagem , Recursos Humanos de Enfermagem Hospitalar , Competência Profissional , Estados Unidos
7.
Laryngoscope ; 122(12): 2781-5, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22952115

RESUMO

OBJECTIVES/HYPOTHESIS: To study the incidence and implications of vocal fold paresis (VFP) following congenital neonatal cardiac surgery. STUDY DESIGN: Retrospective chart review. METHODS: All neonates who underwent median sternotomy for cardiac surgery from May 2007 to May 2008 were evaluated. Flexible laryngoscopy was performed to evaluate vocal fold function after extubation. Swallow evaluation and a modified barium swallow study were performed prior to initiating oral feeding if the initial screening was abnormal. RESULTS: A total of 101 neonates underwent cardiac surgery during the study period. Ninety-four patients underwent a median sternotomy, and 76 of these were included in the study. Fifteen (19.7%) had vocal fold paresis (VFP) postoperatively. Almost 27% of the patients with aortic arch surgery had VFP while only 4.1% of the patients with nonaortic arch surgery developed VFP (P=0.02) Those patients who underwent aortic arch surgery weighed significantly less (P<0.01). All the patients with VFP had significant morbidity related to swallowing and nutrition (P=0.01) and required longer postsurgical hospitalization (P=0.02). CONCLUSIONS: The reported incidence of VFP following cardiac surgery via median sternotomy ranges between 1.7% and 67% depending on the type of surgery and the weight of the infant at the time of surgery. In our cohort, 19.7% had VFP. Surgery requiring aortic arch manipulation had a higher incidence of complications and required longer hospitalizations. These results may be used to improve informed consent and to manage postoperative expectations by identifying patients who are at higher risk for complications.


Assuntos
Procedimentos Cirúrgicos Cardíacos/efeitos adversos , Complicações Pós-Operatórias , Paralisia das Pregas Vocais/epidemiologia , Prega Vocal/fisiopatologia , Cardiopatias Congênitas/cirurgia , Humanos , Incidência , Recém-Nascido , Laringoscopia , Estudos Retrospectivos , Estados Unidos/epidemiologia , Paralisia das Pregas Vocais/etiologia , Paralisia das Pregas Vocais/fisiopatologia
8.
J Thorac Cardiovasc Surg ; 142(6): 1358-66, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21703635

RESUMO

OBJECTIVE: There has been considerable improvement in survival after the first stage of palliation for single-ventricle heart disease. Yet, interstage mortality continues to plague this population. Home monitoring has been proposed to reduce interstage mortality. We review our experience after creation of a Single Ventricle Program. METHODS: All infants with a single ventricle heart defect who were admitted to Texas Children's Hospital from the inception of the Single Ventricle Program on September 1, 2007, to January 1, 2010, were included in the Single Ventricle Program cohort. Infants with a single ventricle presenting between January 1, 2002, and August 31, 2007, comprised the pre-Single Ventricle Program group. Anatomic, operative, and postoperative details were noted for all patients. End points included in-hospital death after the first stage of palliation, interstage death (defined as after discharge from the first stage of palliation and before the second stage of palliation), and death or heart transplantation by 1 year of age. Interstage weight gain was also compared. RESULTS: A total of 137 infants with a single ventricle were included in the pre-Single Ventricle Program cohort, and 93 infants were included in the Single Ventricle Program cohort. Anatomic subtypes were similar between groups. There was significant improvement in rate of interstage weight gain, whereas age at the second stage of palliation was significantly reduced in the Single Ventricle Program group. In-house mortality decreased during the Single Ventricle Program era (P = .021). Interstage mortality did not significantly decrease in the Single Ventricle Program group. However, 1-year transplant-free survival improved during the Single Ventricle Program era (P = .002). CONCLUSIONS: The Single Ventricle Program improved interstage weight gain, thereby allowing for early second-stage palliation at an equivalent patient weight. Interstage mortality was not significantly reduced by our program. However, 1-year transplant-free survival was significantly improved in patients in the Single Ventricle Program.


Assuntos
Crescimento , Cardiopatias Congênitas/cirurgia , Ventrículos do Coração/anormalidades , Serviços Hospitalares de Assistência Domiciliar , Cuidados Paliativos , Procedimentos Cirúrgicos Cardíacos , Cardiopatias Congênitas/mortalidade , Humanos , Lactente , Procedimentos de Norwood , Oximetria , Aumento de Peso
9.
Pediatr Crit Care Med ; 8(1): 64-6, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17251885

RESUMO

OBJECTIVE: We present a case of trauma-induced complete atrioventricular block (transient) after placement of a central venous catheter. DESIGN: Case report. SETTING: Neonatal intensive care unit in a tertiary care children's hospital. PATIENT: Review of the medical record and clinical course of a single premature infant. INTERVENTIONS: Removal of central venous catheter, monitoring of the cardiac output exam, and serial monitoring of the arrhythmia profile. MEASUREMENTS AND MAIN RESULTS: Trauma-induced complete atrioventricular block from placement of the central venous catheter resolved in 9 days, obviating the need for pacemaker placement. CONCLUSIONS: Complete atrioventricular block is an infrequent complication of central venous catheter placement and may require several days to resolve.


Assuntos
Cateterismo Venoso Central/efeitos adversos , Bloqueio Cardíaco/etiologia , Índice de Apgar , Eletrocardiografia , Seguimentos , Bloqueio Cardíaco/diagnóstico , Humanos , Recém-Nascido , Unidades de Terapia Intensiva Neonatal , Masculino , Fatores de Tempo
10.
J Heart Lung Transplant ; 22(3): 276-80, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12633694

RESUMO

BACKGROUND: Acute rejection commonly occurs within the first year after heart transplantation, and then decreases in frequency with time. Recently, the long-term utility of endomyocardial biopsy during routine annual catheterization has been questioned. The purpose of this study was to retrospectively review the prevalence of biopsy-proven rejection during routine annual catheterization in our patient population, determine whether biopsies late after transplant are useful, and identify factors that correlate with late unsuspected rejection. METHODS: Biopsy results from the annual catheterization were evaluated from 1986 to August 2000. The prevalence of moderate rejection was evaluated and compared with the patient's immunosuppressive regimen; the prevalence of late rejection; and how late rejection correlated with recipient age, number of first-year rejections and presence of sub-therapeutic cyclosporine. RESULTS: A total of 1108 biopsies were performed in 269 children with a mean follow-up of 5 +/- 3 years (median 5 years, range 1 to 11 years). Three-drug immunosuppressive therapy, including steroids, was used in 93 patients. There was a persistent 8% to 10% prevalence of moderate rejection at up to 10 years post-transplantation. Moderate rejection was more likely in patients: (1). on 3-drug immunosuppressive therapy; (2). with a recipient age >1 year; and (3). with a relatively lower cyclosporine level. CONCLUSIONS: These data suggest that continued surveillance of pediatric transplant patients for acute rejection is indicated for long-term follow-up.


Assuntos
Cateterismo Cardíaco , Rejeição de Enxerto/diagnóstico , Transplante de Coração , Doença Aguda , Biópsia , Criança , Pré-Escolar , Seguimentos , Rejeição de Enxerto/epidemiologia , Transplante de Coração/imunologia , Humanos , Imunossupressores/uso terapêutico , Miocárdio/patologia , Prevalência , Estudos Retrospectivos , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...